Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 7 | $241,410 |
| Sells | 10 | $495,964 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 09 Aug 2024 16:30 | GLYC | GLYCOMIMETICS INC | INVUS PUBLIC EQUITIES, L.P. | 10% | 08 Aug 2024 | Sale | 260,873 | 0.1917 | 50,009 | D |
| 09 Aug 2024 16:30 | GLYC | GLYCOMIMETICS INC | INVUS PUBLIC EQUITIES, L.P. | 10% | 07 Aug 2024 | Sale | 61,488 | 0.1821 | 11,197 | D |
| 07 Aug 2024 16:30 | GLYC | GLYCOMIMETICS INC | INVUS PUBLIC EQUITIES, L.P. | 10% | 06 Aug 2024 | Sale | 55,732 | 0.1828 | 10,188 | D |
| 07 Aug 2024 16:30 | GLYC | GLYCOMIMETICS INC | INVUS PUBLIC EQUITIES, L.P. | 10% | 05 Aug 2024 | Sale | 164,523 | 0.1884 | 30,996 | D |
| 05 Aug 2024 16:53 | GLYC | GLYCOMIMETICS INC | INVUS PUBLIC EQUITIES, L.P. | 10% | 02 Aug 2024 | Sale | 286,200 | 0.2004 | 57,354 | D |
| 05 Aug 2024 16:53 | GLYC | GLYCOMIMETICS INC | INVUS PUBLIC EQUITIES, L.P. | 10% | 01 Aug 2024 | Sale | 63,564 | 0.2162 | 13,743 | D |
| 30 Jul 2024 17:16 | GLYC | GLYCOMIMETICS INC | INVUS PUBLIC EQUITIES, L.P. | 10% | 30 Jul 2024 | Sale | 756,835 | 0.2209 | 167,185 | D |
| 30 Jul 2024 17:16 | GLYC | GLYCOMIMETICS INC | INVUS PUBLIC EQUITIES, L.P. | 10% | 29 Jul 2024 | Sale | 363,949 | 0.2353 | 85,637 | D |
| 30 Jul 2024 17:16 | GLYC | GLYCOMIMETICS INC | INVUS PUBLIC EQUITIES, L.P. | 10% | 26 Jul 2024 | Sale | 258,335 | 0.2417 | 62,440 | D |
| 24 Jun 2024 16:29 | GLYC | GLYCOMIMETICS INC | ROCK EDWIN | Chief Medical Officer | 21 Jun 2024 | Purchase | 115,000 | 0.2671 | 30,716 | D |
| 24 Jun 2024 16:29 | GLYC | GLYCOMIMETICS INC | ROCK EDWIN | Chief Medical Officer | 20 Jun 2024 | Purchase | 190,000 | 0.2532 | 48,108 | D |
| 20 Jun 2024 16:15 | GLYC | GLYCOMIMETICS INC | HAHN BRIAN M. | SVP Finance, CFO | 18 Jun 2024 | Purchase | 17,500 | 0.2477 | 4,335 | D |
| 25 Sep 2023 16:21 | GLYC | GLYCOMIMETICS INC | ROCK EDWIN | Chief Medical Officer | 22 Sep 2023 | Purchase | 30,403 | 1.38 | 41,956 | D |
| 25 Sep 2023 16:21 | GLYC | GLYCOMIMETICS INC | ROCK EDWIN | Chief Medical Officer | 21 Sep 2023 | Purchase | 35,000 | 1.38 | 48,300 | D |
| 18 May 2023 16:27 | GLYC | GLYCOMIMETICS INC | HAHN BRIAN M. | SVP Finance, CFO | 17 May 2023 | Sale | 3,700 | 1.95 | 7,215 | D |
| 11 May 2023 17:08 | GLYC | GLYCOMIMETICS INC | JUNIUS DANIEL M | Director | 10 May 2023 | Purchase | 30,000 | 1.56 | 46,800 | D |
| 09 May 2023 17:00 | GLYC | GLYCOMIMETICS INC | JOHNSON BRUCE S | SVP & Chief Commercial Officer | 08 May 2023 | Purchase | 13,500 | 1.57 | 21,195 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)